All News
|
News Release
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
Showing 4 out of 1684 results
NHLBI in the Press
Researchers are reporting a new way of analyzing genetic test data that may help identify people at high risk of heart disease and other common medical conditions.